ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1060

Demographic Risk Factors, Social Vulnerability Index, and Mortality in Patients with Systemic Lupus Erythematosus

Christine Kim1, Katherine Mitchell2, Changyong Feng1 and Allen Anandarajah3, 1University of Rochester, Rochester, NY, 2University of Rochester, Rochester, 3University of Rochester Medical Center, Rochester, NY

Meeting: ACR Convergence 2025

Keywords: Minority Health, Mortality, socioeconomic factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1055–1087) Healthcare Disparities in Rheumatology Posters

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease with multi-organ involvement that is characterized by relapses and remissions. Ethnicity, socioeconomic status, gender, age, education level, and healthcare access are associated with poorer disease outcomes among patients with SLE. The social vulnerability index (SVI), developed by the Centers for Disease Control and Prevention (CDC), is a measure of demographic and socioeconomic factors that adversely affect health outcomes. We aim to determine the association between SVI and mortality in our lupus cohort.

Methods: This was a single-center retrospective study of all SLE patients hospitalized at the University of Rochester Strong Memorial Hospital between July 2016 and June 2023. We analyzed the age, race and ethnicity, mortality, and SVI among all those hospitalized. SVI is measured on a percentile ranking from 0 to 1, with higher percentiles indicating more social vulnerability. Additionally, SVI is divided into 4 subcategories (socioeconomic status, household characteristics, racial & ethnic minority status, and housing type & transportation) which are also assessed on a percentile scale from 0 to 1. The SVI and the scores of the 4 subcategories were determined based on publicly available CDC data and the patient’s current addresses. The ANOVA and chi-squared tests were used to assess differences in demographic risk factors and mortality. The Cox regression was used to assess the hazard ratios for SVI and its subcategories.

Results: A total of 405 patients met criteria for a diagnosis of SLE. There were 75 deaths during the specified time period (Table 1). The mean age of death for the entire cohort was 61.51 years. The mean age of death for those patients identifying as White was 69.59 years, 55.72 years for Black patients, and 49 years for Hispanic patients (p-value = 0.0019) (Table 2). Although the age of mortality was not significantly different between females and males (61.46 vs 61.71 years, p-value = 0.9583), there was a significant difference in mortality rates (16.6% in females vs 34.9% in males, p-value = 0.0035). The average age of death of patients in the first quartile of SVI was 65.53 years of age compared to 56.81 years of age for patients in the last quartile of SVI. Patients of higher social vulnerability had a significantly higher risk of death with a hazard ratio of 3.38 (p-value = 0.004) (Table 2, Figure 1). Higher percentile scores were associated with significantly higher risk of death for all subcategories of SVI, except for housing type & transportation (Table 2, Figure 1).

Conclusion: There is a significant difference in age of mortality among hospitalized SLE patients based on race. Additionally, patients with a higher social vulnerability score are at a higher risk of death. Among the four subcategories of social vulnerability, socioeconomic status, household characteristics, racial & ethnic minority status contributed to significantly increased risk of death while housing type & transportation did not. Providing additional care and developing specific interventions to overcome barriers to care may help reduce mortality among lupus patients with high SVI scores.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: C. Kim: None; K. Mitchell: None; C. Feng: None; A. Anandarajah: None.

To cite this abstract in AMA style:

Kim C, Mitchell K, Feng C, Anandarajah A. Demographic Risk Factors, Social Vulnerability Index, and Mortality in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/demographic-risk-factors-social-vulnerability-index-and-mortality-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/demographic-risk-factors-social-vulnerability-index-and-mortality-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology